Horizon Discovery rejects bid from Abcam

On May 2, gene editing company Horizon Discovery Group plc (LSE:HZD) rejected an April 19 proposal from Abcam plc (LSE:ABC) to acquire the company for 181p per share, or about £270 million ($371 million). The price is about a 21% premium to Horizon's close of 149p on April 18, the day before the offer was made...